Table 1

Demographic and clinical characteristic of the patients at baseline

Group 1
HbA1c <7.0%
Group 2
HbA1c ≥7.0%
n1121
Sex (male/female)7/414/7
Age (years)19.4±0.920.8±1.4
Height (cm)175±2.2176±2.0
Weight (kg)68.6±6.464.0±3.1
BMI (kg/m²)21.9±1.720.4±0.8
Systolic blood pressure (mm Hg)127±7.0117±3.9
Diastolic blood pressure (mm Hg)81.3±6.669.4±3.9
Duration of symptoms (weeks)*5.5±1.76.7±2.3
Duration of insulin treatment (weeks)2.6±0.52.7±0.5
Insulin dose (IU/day)28.3±5.137.2±4.3
HbA1c (%)8.8±0.69.1±0.3
HbA1c (mmol/mol)72.6±5.276.5±2.9
Mean blood glucose (mg/dL)†111±8.0121±4.2
Islet cell antibody positive (%)7584
  • *Symptoms due to hyperglycaemia prior to diabetes diagnosis.

  • †Based on five values during the day of neurological assessment.

  • BMI, body mass index; HbA1c, glycated haemoglobin.